StonvexLoading…
StonvexStonvexStonvexCore line items from CHRN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $12.80M | $17.93M | $18.28M | $12.91M |
Operating Income | $-13.33M | $-10.46M | $-15.11M | $-15.56M |
Net Income | $-11.70M | $-11.33M | $-15.20M | $-15.08M |
EPS (Diluted) | $-4.91 | $-8.43 | $-1.10 | $-1.16 |
Total Assets | $20.11M | $26.65M | $28.92M | $40.90M |
Total Liabilities | $11.08M | $13.95M | $16.31M | $15.46M |
Cash & Equivalents | $1.17M | $4.49M | $8.64M | $20.52M |
Free Cash Flow OCF − CapEx | $-11.99M | $-9.88M | $-12.21M | $-14.88M |
Shares Outstanding | 3.56M | 1.48M | 14.85M | 13.20M |